BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21732144)

  • 21. Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome.
    Lew JI; Irvin GL
    Surgery; 2009 Dec; 146(6):1021-7. PubMed ID: 19879612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufficiency.
    Beyer TD; Chen EL; Nilubol N; Prinz RA; Solorzano CC
    J Surg Res; 2007 Nov; 143(1):145-50. PubMed ID: 17950085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical treatment of hyperparathyroidism].
    Târcoveanu E; Niculescu D; Moldovanu R; Cotea E; Vasilescu A; Dănilă N; Lăzescu D; Ferariu D; Crumpei F; Ichim M; Zbranca E
    Chirurgia (Bucur); 2009; 104(5):531-44. PubMed ID: 19943551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years.
    Goldfarb M; Gondek S; Irvin GL; Lew JI
    Surgery; 2011 Dec; 150(6):1076-84. PubMed ID: 22136824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
    Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
    Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative parathyroid hormone (IOPTH) assay might be better than the second-generation assay in parathyroidectomy for primary hyperparathyroidism.
    Lang BH; Fung MMH
    Surgery; 2021 Jan; 169(1):109-113. PubMed ID: 32402543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraoperative parathyroid hormone measurement during parathyroidectomy for treatment of primary hyperparathyroidism: When should you end the operation?
    Mak NTJJ; Li J; Vasilyeva E; Hiebert J; Guo M; Lustig D; Holmes D; Wiseman SM
    Am J Surg; 2020 May; 219(5):785-789. PubMed ID: 32169248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biochemical severity of primary hyperparathyroidism correlates with the localization accuracy of sestamibi and surgeon-performed ultrasound.
    Hughes DT; Sorensen MJ; Miller BS; Cohen MS; Gauger PG
    J Am Coll Surg; 2014 Nov; 219(5):1010-9. PubMed ID: 25086814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of intraoperative PTH for primary hyperparathyroidism due to multigland disease.
    Cayo AK; Sippel RS; Schaefer S; Chen H
    Ann Surg Oncol; 2009 Dec; 16(12):3450-4. PubMed ID: 19760044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism.
    Denizot A; Pucini M; Chagnaud C; Botti G; Henry JF
    Am J Surg; 2001 Jul; 182(1):15-9. PubMed ID: 11532408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism.
    Meyer SK; Zorn M; Frank-Raue K; Büchler MW; Nawroth P; Weber T
    Eur J Endocrinol; 2009 Feb; 160(2):275-81. PubMed ID: 19004983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 25-hydroxyvitamin D status does not affect intraoperative parathyroid hormone dynamics in patients with primary hyperparathyroidism.
    Adler JT; Sippel RS; Chen H
    Ann Surg Oncol; 2010 Nov; 17(11):2958-62. PubMed ID: 20544293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial blood pressure, serum calcium and PTH in elderly men with parathyroid tumors and primary hyperparathyroidism.
    Lumachi F; Camozzi V; Luisetto G; Zanella S; Basso SM
    Anticancer Res; 2011 Nov; 31(11):3969-72. PubMed ID: 22110228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analyses of risk factors for temporarily inhibited parathyroid hormone secretion of postoperative primary hyperparathyroidism].
    Liu X; Zhao T; Wang JC; Shen H; Wang Q; Xin YH; Wei BB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):497-500. PubMed ID: 32842365
    [No Abstract]   [Full Text] [Related]  

  • 35. Intraoperative Parathyroid Hormone Assay Remains Predictive of Cure in Renal Impairment in Patients with Single Parathyroid Adenomas.
    Egan RJ; Iliff H; Stechman MJ; Scott-Coombes DM
    World J Surg; 2018 Sep; 42(9):2835-2839. PubMed ID: 29497805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism.
    Carneiro DM; Solorzano CC; Irvin GL
    J Am Coll Surg; 2004 Dec; 199(6):849-53; discussion 853-5. PubMed ID: 15555964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.
    Govind K; Paruk IM; Motala AA
    BMC Endocr Disord; 2024 Apr; 24(1):53. PubMed ID: 38664758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence after successful parathyroidectomy-Who should we worry about?
    Shirali AS; Wu SY; Chiang YJ; Graham PH; Grubbs EG; Lee JE; Perrier ND; Fisher SB
    Surgery; 2022 Jan; 171(1):40-46. PubMed ID: 34340820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of intraoperative parathyroid hormone predicts long-term operative success.
    Westerdahl J; Lindblom P; Bergenfelz A
    Arch Surg; 2002 Feb; 137(2):186-90. PubMed ID: 11822958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistently elevated parathyroid hormone levels after parathyroid surgery.
    Wang TS; Ostrower ST; Heller KS
    Surgery; 2005 Dec; 138(6):1130-5; discussion 1135-6. PubMed ID: 16360400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.